Rigel Pharmaceuticals RIGL Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Rigel Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's quick ratio?
- Rigel Pharmaceuticals (RIGL) reported quick ratio of 2.5× in Q1 2026.
- How has Rigel Pharmaceuticals's quick ratio changed year-over-year?
- Rigel Pharmaceuticals's quick ratio increased by 16.7% year-over-year, from 2.1× to 2.5×.
- What is the long-term trend for Rigel Pharmaceuticals's quick ratio?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's quick ratio has grown at a 1.5% compound annual growth rate (CAGR), from 2.1× to 2.3×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.